CNS Pharmaceuticals (CNSP) Institutional Ownership → A letter is coming from the 'Bureau of the Fiscal Service'. (From Stansberry Research) (Ad) Free CNSP Stock Alerts $0.22 -0.01 (-4.41%) (As of 05/17/2024 ET) Add Compare Share Share OwnershipStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Institutional Ownership Changes (13F Filings) for CNS Pharmaceuticals (NASDAQ:CNSP)CurrentInstitutional OwnershipPercentage14.02%Number ofInstitutional Buyers(last 12 months)4TotalInstitutional Inflows(last 12 months)$304.58KNumber ofInstitutional Sellers(last 12 months)0 Get CNSP Insider Trade Alerts Want to know when executives and insiders are buying or selling CNS Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data CNSP Institutional Buying and Selling by Quarter Ad InvestorPlaceElon’s New Device is About to Shock the WorldUsing this device you see above… Elon Musk just tested a new type of A.I. that according to Wired Magazine will usher in… “The next step in human evolution.” Click here to see the details because there’s a lot of money at stake. CNS Pharmaceuticals Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/13/2024 Armistice Capital LLC122,000$155K0.0%N/A1.965% 1/17/2024 Smith Anglin Financial LLC50,000$64K0.0%N/A0.952% 8/7/2023 Acadian Asset Management LLC22,292$49K0.0%N/A1.000% 7/12/2023 FSM Wealth Advisors LLC16,334$38K0.0%N/A0.732% 9/17/2021Virtu Financial LLC20,745$41K0.0%-49.8%0.076% 8/13/2021 Renaissance Technologies LLC432,109$847K0.0%-40.2%1.704% 8/13/2021 Geode Capital Management LLC100,196$196K0.0%+64.8%0.395% 8/13/2021 Vanguard Group Inc.599,309$1.18M0.0%+326.6%2.363% 8/11/2021Commonwealth Equity Services LLC20,000$39K0.0%N/A0.079% 5/19/2021Virtu Financial LLC41,310$99K0.0%N/A0.163% 5/18/2021 Citadel Advisors LLC92,404$221K0.0%N/A0.364% 5/18/2021 Jane Street Group LLC13,747$33K0.0%N/A0.054% 5/17/2021 Goldman Sachs Group Inc.11,566$28K0.0%N/A0.046% 5/13/2021 Renaissance Technologies LLC722,760$1.73M0.0%N/A2.850% 5/13/2021 Bank of New York Mellon Corp43,659$104K0.0%N/A0.172% 5/12/2021 Northern Trust Corp32,094$77K0.0%N/A0.127% 5/12/2021 Geode Capital Management LLC60,784$145K0.0%N/A0.240% 2/16/2021 Warberg Asset Management LLC14,000$25K0.0%N/A0.059% 11/12/2020 Essex Investment Management Co. LLC61,563$108K0.0%-13.5%0.370% (Data available from 1/1/2016 forward) CNSP Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of CNSP shares? During the previous two years, the following institutional investors and hedge funds held shares of CNS Pharmaceuticals shares: Armistice Capital LLC ($155K), Smith Anglin Financial LLC ($64K), and Acadian Asset Management LLC ($49K), FSM Wealth Advisors LLC ($38K).Learn more on CNSP's institutional investors. What percentage of CNS Pharmaceuticals stock is owned by institutional investors? 14.02% of CNS Pharmaceuticals stock is owned by institutional investors. Learn more on CNSP's institutional investor holdings. Which institutional investors have been buying CNS Pharmaceuticals stock? The following institutional investors have purchased CNS Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($122K), Smith Anglin Financial LLC ($50K), Acadian Asset Management LLC ($22.29K), and FSM Wealth Advisors LLC ($16.33K). How much institutional buying is happening at CNS Pharmaceuticals? Institutional investors have bought a total of 210,626 shares in the last 24 months. This purchase volume represents approximately $304.58K in transactions. Related Companies: CMND Institutional Ownership DRMA Institutional Ownership CYTO Institutional Ownership GLMD Institutional Ownership SLRX Institutional Ownership NTBL Institutional Ownership ALLR Institutional Ownership QLGN Institutional Ownership SXTP Institutional Ownership AGRX Institutional Ownership This page (NASDAQ:CNSP) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Presidential candidate you should REALLY be worried aboutStansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CNS Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
